In the present study, we systematically investigate how miR-223 coordinates the PPAR-γ/FOXO1 signaling axis to reprogram macrophage phenotypes in DSS-induced colitis—an unexplored therapeutic nexus bridging epigenetic regulation and mucosal immunity. This evidence concerns the gene FOXO1 and colitis.